Theriva Biologics, Inc.
TOVX
$0.4996
-$0.0304-5.74%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.01M | 11.61M | 16.41M | 16.59M | 18.26M |
| Total Receivables | 1.70M | 3.32M | 2.00M | 1.93M | 1.91M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 687.00K | 984.00K | 763.00K | 979.00K | 1.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 79.00K | 365.00K | 359.00K | 213.00K | 364.00K |
| Total Current Assets | 12.48M | 16.28M | 19.53M | 19.72M | 21.66M |
|
|
|||||
| Total Current Assets | 12.48M | 16.28M | 19.53M | 19.72M | 21.66M |
| Net Property, Plant & Equipment | 1.42M | 1.54M | 1.74M | 1.86M | 2.01M |
| Long-term Investments | -- | -- | -- | 1.47M | 5.57M |
| Goodwill | -- | -- | -- | 1.47M | 5.57M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.26M | 17.53M | 18.83M | 19.36M | 19.49M |
| Total Assets | 32.16M | 35.35M | 40.11M | 42.39M | 48.73M |
|
|
|||||
| Total Accounts Payable | 437.00K | 859.00K | 756.00K | 935.00K | 571.00K |
| Total Accrued Expenses | 4.32M | 4.51M | 5.05M | 4.46M | 3.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 619.00K | 600.00K | 606.00K | 575.00K | 560.00K |
| Total Finance Division Other Current Liabilities | 2.77M | 1.61M | 916.00K | 880.00K | 886.00K |
| Total Other Current Liabilities | 2.77M | 1.61M | 916.00K | 880.00K | 886.00K |
| Total Current Liabilities | 8.15M | 7.59M | 7.32M | 6.85M | 6.01M |
|
|
|||||
| Total Current Liabilities | 8.15M | 7.59M | 7.32M | 6.85M | 6.01M |
| Long-Term Debt | 1.50M | 92.00K | 98.00K | 93.00K | 159.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 732.00K | 873.00K | 1.04M | 1.16M | 1.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.28M | 7.74M | 7.02M | 6.64M | 7.14M |
| Total Liabilities | 16.66M | 16.29M | 15.47M | 14.74M | 14.61M |
|
|
|||||
| Common Stock & APIC | 355.60M | 355.50M | 355.34M | 349.70M | 346.70M |
| Retained Earnings | -339.30M | -334.97M | -330.53M | -322.80M | -314.48M |
| Treasury Stock & Other | -812.00K | -1.47M | -176.00K | -997.00K | -825.00K |
| Total Common Equity | 15.50M | 19.07M | 24.64M | 25.90M | 31.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 1.75M | 2.73M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 1.75M | 2.73M |
|
|
|||||
| Total Common Equity | 15.50M | 19.07M | 24.64M | 25.90M | 31.39M |
| Total Preferred Equity | -- | -- | -- | 1.75M | 2.73M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.50M | 19.07M | 24.64M | 27.65M | 34.12M |
|
|
|||||